SHL Medical expert to speak at Novartis Campus in Basel
We are pleased to announce our participation in the upcoming Drug-Device Combination Products for Parenteral Use workshop. The event is scheduled to take place in Basel, Switzerland on June 25-26.
In this workshop, our Business Development Senior Manager EMEA, James Mellman, PhD, has been invited to speak at a roundtable session with representatives from other packaging and device companies. Aside from delving into the technological intricacies of drug-device combination products, the session will also explore the business aspects of the collaborative product development between pharma and device technology providers. This forum is a great opportunity to further demonstrate SHL’s dedication to supporting the development of innovative formulations and shaping the future of drug-device combination products.
In addition to the knowledge-sharing session, SHL will also hold a tabletop exhibition. Attendees can explore our comprehensive self-injection portfolio – from Molly® autoinjectors to Maggie® autoinjectors – and gain insights into our vertically integrated manufacturing capabilities. Participants will also be able to interact with our experts on site and learn about our global expansion strategies, sustainability initiatives, and more.
We are excited about the opportunity to contribute our expertise and insights to this workshop and look forward to enriching the exchange of ideas and experiences.
Meet our speaker!
Topic |
Speaker |
Time |
Roundtable with other device companies |
James Mellman, PhD Business Development Senior Manager EMEA, SHL Medical |
June 25 10:00 AM – 18:00 PM CEST |
Where : Novartis Campus, Basel, Switzerland
When : June 25-26